SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 12.97 |
| Enterprise Value ($M) | 12.63 |
| Book Value ($M) | 4.31 |
| Book Value / Share | 0.12 |
| Price / Book | 3.01 |
| NCAV ($M) | 1.49 |
| NCAV / Share | 0.04 |
| Price / NCAV | 8.69 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.84 |
| Return on Assets (ROA) | -3.58 |
| Return on Equity (ROE) | -16.54 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.76 |
| Current Ratio | 1.76 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 5.25 |
| Assets | 8.07 |
| Liabilities | 3.76 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -21.49 |
| Net Income | -21.27 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -7.24 |
| Cash from Investing | 0.00 |
| Cash from Financing | 4.92 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.96 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 6,811 | 25,203 | 27.02 | |
| 44,809 | 316,087 | 14.18 | |
| 32,576 | 24,297 | 134.07 | |
| 7,825 | 4,914 | 159.24 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CNSP – CNS Pharmaceuticals, Inc. | CNTX – Context Therapeutics Inc. |
| COCP – Cocrystal Pharma, Inc. | CORT – Corcept Therapeutics Incorporated |
| COYA – Coya Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io